Document is current
Any future updates will be listed below
-
Authors
Bronze, Sergio
Shenoy, Shabari
Agrawal, Manasi
Polydorides, Alexandros D.
Colombel, Jean-Frédéric
Rodríguez-Lago, Iago
Ungaro, Ryan C.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK129762-03)
Eusko Jaurlaritza (2020111061)
- License Information
-
More Information
Article History
Received: 17 July 2025
Accepted: 10 September 2025
First Online: 19 September 2025
Declarations
:
: SB has no conflicts to disclose. SS has no conflicts to disclose. MA is reports consulting fees from Douglas Pharmaceutical. JFC reports receiving research grants from AbbVie, Janssen Pharmaceuticals, Prometheus, Takeda, and Bristol Myers Squibb; receiving payment for lectures from AbbVie, and Takeda; receiving consulting fees from AbbVie, Amgen, AnaptysBio, Allergan, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene Corporation, Celltrion, Eli Lilly, Ferring Pharmaceuticals, Galmed Research, Glaxo Smith Kline, Genentech (Roche), Janssen Pharmaceuticals, Kaleido Biosciences, Immunic, Invea, Iterative Scopes, Merck, Landos, Microba Life Science, Novartis, Otsuka Pharmaceutical, Pfizer, Protagonist Therapeutics, Prometheus, Sanofi, Seres, Takeda, Teva, TiGenix, Vifor; and hold stock options in Intestinal Biotech Development. IRL has received financial support for traveling and educational activities from or has served as an advisory board member for Abbvie, Adacyte, Biogen, Celltrion, Chiesi, Faes Farma, Ferring, Fresenius Kabi, Galapagos, Janssen, Lilly, Mirum Pharmaceuticals, MSD, Pfizer, Roche, Takeda, and Tillotts Pharma; and research support from AbbVie. RU has served as a consultant and/or advisory board member for AbbVie, Bristol Myers Squibb, Celltrion, Genentech, Inotrem, Lilly, Janssen, Pfizer, Roivant, and Takeda and has received research funding from AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, and Pfizer.
